Literature DB >> 23054402

Predictors of outcome in stable outpatients with peripheral artery disease.

Carmen Sanclemente1, Montserrat Yeste, Carmen Suarez, Ramón Coll, Eduardo Aguilar, Joan Carles Sahuquillo, Rosa Lerma, Manuel Monreal.   

Abstract

Patients with peripheral artery disease (PAD) are at increased risk for subsequent ischemic events. We used data from the FRENA Registry to find predictors of subsequent myocardial infarction (MI), ischemic stroke, and limb amputation in stable outpatients with PAD. As of January 2012, 1,270 patients with PAD were recruited, of whom 1,042 (82 %) had Fontaine stage II; 113 (8.9 %) stage III; and 115 (9.1 %) stage IV. Over a mean follow-up of 14 months, 35 patients developed MI, 25 had stroke, 39 underwent limb amputation, and 91 died. Among patients with Fontaine stage II, the incidence of MI (2.09 events per 100 patient-years; 95 % CI 1.43-2.97) or stroke (0.93; 95 % CI 0.52-1.56) was similar to that of limb amputation (3.22; 95 % CI 2.37-4.29). On multivariate analysis, patients with diabetes [hazard ratio (HR) 2.09; 95 % CI 1.05-4.18], prior coronary disease (HR 5.35; 95 % CI 2.24-12.8), or atrial fibrillation (HR 3.11; 95 % CI 1.52-6.37) were at increased risk for MI; female (HR 2.94; 95 % CI 1.32-6.67), those with prior stroke (HR 5.21; 95 % CI 1.22-22.2) or atrial fibrillation (HR 3.37; 95 % CI 1.45-7.85) at increased risk for stroke; and female (HR 2.38; 95 % CI 1.23-4.55), those with diabetes (HR 3.50; 95 % CI 1.58-7.73) or advanced stages of PAD were at increased risk for limb amputation. Prior coronary artery disease, diabetes and atrial fibrillation predicted subsequent MI; female gender, prior stroke and atrial fibrillation predicted stroke; and female gender, diabetes, and advanced stages of PAD predicted limb amputation.

Entities:  

Mesh:

Year:  2012        PMID: 23054402     DOI: 10.1007/s11739-012-0854-1

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  23 in total

1.  Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group.

Authors:  A B Newman; L Shemanski; T A Manolio; M Cushman; M Mittelmark; J F Polak; N R Powe; D Siscovick
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

2.  Predictors of overall and cardiovascular mortality in peripheral arterial disease.

Authors:  L Pasqualini; G Schillaci; G Vaudo; S Innocente; G Ciuffetti; E Mannarino
Journal:  Am J Cardiol       Date:  2001-11-01       Impact factor: 2.778

3.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

4.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.

Authors:  Sidney C Smith; Jerilyn Allen; Steven N Blair; Robert O Bonow; Lawrence M Brass; Gregg C Fonarow; Scott M Grundy; Loren Hiratzka; Daniel Jones; Harlan M Krumholz; Lori Mosca; Richard C Pasternak; Thomas Pearson; Marc A Pfeffer; Kathryn A Taubert
Journal:  Circulation       Date:  2006-05-16       Impact factor: 29.690

5.  Long-term mortality and its predictors in patients with critical leg ischaemia. The I.C.A.I. Group (Gruppo di Studio dell'Ischemia Cronica Critica degli Arti Inferiori). The Study Group of Criticial Chronic Ischemia of the Lower Exremities.

Authors: 
Journal:  Eur J Vasc Endovasc Surg       Date:  1997-08       Impact factor: 7.069

6.  Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.

Authors:  Thomas F Rehring; Ryan S Stolcpart; H Whitton Hollis
Journal:  J Vasc Surg       Date:  2008-04-18       Impact factor: 4.268

7.  Mortality over a period of 10 years in patients with peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

8.  Exact estimates for a rate ratio.

Authors:  D O Martin; H Austin
Journal:  Epidemiology       Date:  1996-01       Impact factor: 4.822

9.  Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA Registry.

Authors:  M Camafort; L R Alvarez-Rodríguez; J F S Muñoz-Torrero; J C Sahuquillo; L López-Jiménez; R Coll; M Monreal
Journal:  Diabet Med       Date:  2011-01       Impact factor: 4.359

Review 10.  Matrix metalloproteinases and peripheral arterial disease.

Authors:  Chiara Busti; Emanuela Falcinelli; Stefania Momi; Paolo Gresele
Journal:  Intern Emerg Med       Date:  2009-07-21       Impact factor: 3.397

View more
  2 in total

1.  A Review of the Relationship of Atrial Fibrillation and Acute Coronary Syndrome.

Authors:  Bory Kea; Tahroma Alligood; Vincent Manning; Merritt Raitt
Journal:  Curr Emerg Hosp Med Rep       Date:  2016-07-06

Review 2.  Atrial fibrillation and risk of cardiovascular events and mortality in patients with symptomatic peripheral artery disease: A meta-analysis of prospective studies.

Authors:  Mislav Vrsalović; Ana Vrsalović Presečki
Journal:  Clin Cardiol       Date:  2017-12-15       Impact factor: 2.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.